1. Home
  2. FIZZ vs ARQT Comparison

FIZZ vs ARQT Comparison

Compare FIZZ & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Beverage Corp.

FIZZ

National Beverage Corp.

HOLD

Current Price

$33.83

Market Cap

3.2B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$23.11

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIZZ
ARQT
Founded
1985
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
FIZZ
ARQT
Price
$33.83
$23.11
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
6
Target Price
$35.00
$34.00
AVG Volume (30 Days)
162.1K
973.7K
Earning Date
03-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
5.29
88.79
EPS
1.53
N/A
Revenue
$1,201,354,000.00
$376,072,000.00
Revenue This Year
$0.14
$34.85
Revenue Next Year
$3.33
$29.39
P/E Ratio
$22.12
N/A
Revenue Growth
0.81
91.34
52 Week Low
$31.21
$12.42
52 Week High
$47.88
$31.77

Technical Indicators

Market Signals
Indicator
FIZZ
ARQT
Relative Strength Index (RSI) 49.26 45.73
Support Level $32.53 $22.56
Resistance Level $35.86 $23.46
Average True Range (ATR) 0.81 0.89
MACD 0.00 -0.06
Stochastic Oscillator 46.24 25.17

Price Performance

Historical Comparison
FIZZ
ARQT

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: